COVID-19Regulatory

Coronavirus Is Likely to Generate Telltale Signs, Fauci Says

April 30, 2020 / By John Lauerman

Most people who’ve had the coronavirus probably develop markers of the infection, according to Anthony Fauci, the scientist who’s leading the U.S. response to the pandemic.

Fauci, director of the National Institute of Allergy and Infectious Diseases, said it would be “extremely unusual” if patients did not develop antibodies, which often bestow immunity on people who’ve been infected with a virus. Other experts have cast doubt on whether this happens in everyone with the new coronavirus, fueling concerns about the insidious nature of the illness.

“I’d be careful about saying people who get infected don’t have any antibodies,” Fauci said in an interview. “It would be almost unprecedented.”

The dependable appearance of antibodies following Covid-19 infections would be highly reassuring as governments move to restart economies from lockdowns. Tests for them can show who’s been infected by the pathogen and how far it’s spread — and, potentially, how many people have developed immunity that could allow them to work in virus-exposed jobs with less risk of illness.

READ THE REST HERE

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
Close